Julie Mak

2.2k total citations
13 papers, 213 citations indexed

About

Julie Mak is a scholar working on Genetics, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Julie Mak has authored 13 papers receiving a total of 213 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 3 papers in Pathology and Forensic Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Julie Mak's work include BRCA gene mutations in cancer (8 papers), Genetic factors in colorectal cancer (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Julie Mak is often cited by papers focused on BRCA gene mutations in cancer (8 papers), Genetic factors in colorectal cancer (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Julie Mak collaborates with scholars based in United States, United Kingdom and Canada. Julie Mak's co-authors include Lee-may Chen, Jocelyn Chapman, Emily Chan, Charles Zaloudek, Karuna Garg, Amie Blanco, Joseph T. Rabban, Jane McLennan, C. Bethan Powell and Jennifer L. Young and has published in prestigious journals such as The American Journal of Surgical Pathology, Obstetrics and Gynecology and Gynecologic Oncology.

In The Last Decade

Julie Mak

11 papers receiving 208 citations

Peers

Countries citing papers authored by Julie Mak

Since Specialization

Citations

This map shows the geographic impact of Julie Mak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Mak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Mak more than expected).

Fields of papers citing papers by Julie Mak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Mak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Mak. The network helps show where Julie Mak may publish in the future.

Co-authorship network of co-authors of Julie Mak

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Mak. A scholar is included among the top collaborators of Julie Mak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Mak. Julie Mak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) 2025 ·Genetics in Medicine ·Joanne Ngeow, Jianbang Chiang, (unknown), Judith Balmañà, Ilana Cass, F. Kommoss, William D. Foulkes, Paul A. James, (unknown), Susan Klugman, Alicia A. Livinski, Julie Mak, Nicoleta Voian, Myra Wick, Marc Tischkowitz, Tuya Pal, Douglas R. Stewart, Helen Hanson	0
2	Management of individuals with heterozygous germline pathogenic variants in ATM: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) 2024 ·Genetics in Medicine ·Tuya Pal, Katherine Schon, (unknown), Judith Balmañà, William D. Foulkes, Paul A. James, Susan Klugman, Alicia A. Livinski, Julie Mak, Joanne Ngeow, Nicoleta Voian, Myra Wick, Helen Hanson, Douglas R. Stewart, Marc Tischkowitz	6
3	Changes in Bone Density in Carriers of BRCA1 and BRCA2 Pathogenic Variants After Salpingo-Oophorectomy 2023 ·Obstetrics and Gynecology ·(unknown), Lee-may Chen, Mindy Goldman, Julie Mak, Douglas C. Bauer, John Boscardin, Michael Schembri, Victoria Bae‐Jump, Sue Friedman, Vanessa L. Jacoby	0
4	Same day service: A genetic testing station model to improve germline genetic testing in patients with ovarian cancer 2023 ·Gynecologic Oncology ·Nicole A. Marjon, (unknown), Alexandra F. Freeman, Julie Mak, Stephanie Cheung, (unknown), Amie Blanco, Stefanie Ueda, Lee-may Chen	1
5	An exploration in pitfalls in interpreting SDHB immunohistochemistry 2022 ·Histopathology ·Chien‐Kuang Cornelia Ding, Salina Chan, Julie Mak, Sarah E. Umetsu, Jeffry Simko, Roberto Ruiz‐Cordero, Tara A. Saunders, Emily Chan	8
6	Genetic counseling and testing for Asian Americans: a systematic review 2021 ·Genetics in Medicine ·Jennifer L. Young, Julie Mak, (unknown), Michelle Bass, Mildred K. Cho, Holly K. Tabor	16
7	Prospective Detection of Germline Mutation of Fumarate Hydratase in Women With Uterine Smooth Muscle Tumors Using Pathology-based Screening to Trigger Genetic Counseling for Hereditary Leiomyomatosis Renal Cell Carcinoma Syndrome 2019 ·The American Journal of Surgical Pathology ·Joseph T. Rabban, Emily Chan, Julie Mak, Charles Zaloudek, Karuna Garg	28
8	Detailed Morphologic and Immunohistochemical Characterization of Myomectomy and Hysterectomy Specimens From Women With Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC) 2019 ·The American Journal of Surgical Pathology ·Emily Chan, Joseph T. Rabban, Julie Mak, Charles Zaloudek, Karuna Garg	26
9	Disparities in genetics assessment for women with ovarian cancer: Can we do better? 2018 ·Gynecologic Oncology ·(unknown), Jocelyn Chapman, Julie Mak, Amie Blanco, Lee-may Chen	55
10	Disparities in Genetics Assessment for Women with Ovarian Cancer 2017 ·Gynecologic Oncology ·(unknown), (unknown), Julie Mak, Ana Blanco, (unknown)	2
11	Peritoneal cytology in risk-reducing salpingo-oophorectomy: Implications for cancer outcomes 2012 ·Gynecologic Oncology ·(unknown), (unknown), Julia Fehniger, C. Bethan Powell, James M. Ford, Julie Mak, Joseph T. Rabban	1
12	Surveillance of survivors: Follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers 2011 ·Gynecologic Oncology ·Jocelyn Chapman, C. Bethan Powell, Jane McLennan, (unknown), Julie Mak, (unknown), Lee-may Chen	38
13	Recruitment, Genetic Counseling, and BRCA Testing for Underserved Women at a Public Hospital 2005 ·Genetic Testing ·Robin Lee, Mary Beattie, (unknown), Julie Mak, (unknown), Miriam Komaromy, Laura Esserman, (unknown), Jane McLennan, Lori M. Strachowski, (unknown), John L. Ziegler	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact